← Back to patent-cliff list
CAS 109001-33-4
1-(((1R,2S)-2-(diethylcarbamoyl)-2-phenylcyclopropyl)methyl)-1,3,5,7-tetraazaadamantan-1-ium bromide
Codes: LEVO-015
Application context (from source-drug indications)
Major depressive disorderLevomilnacipran HydrochlorideIschaemic strokeLevomilnacipran HydrochlorideDepressionLevomilnacipran Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Levomilnacipran Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Levomilnacipran HydrochlorideOptimised routesteps: 2total yield: 10.95 kg (Levomilnacipran Hydrochloride)
LEVO-013→1,3,5,7-tetraazaadamantane→1-(((1R,2S)-2-(diethylcarbamoyl)-2-phenylcyclopropyl)methyl)-1,3,5,7-tetraazaadamantan-1-ium bromide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.